Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Targeted Oncology
|
December 6, 2013
Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
Annie Fourrier-Réglat, Denis Smith, Magali Rouyer, et al.
BMC Medicine
|
April 21, 2017
Antidepressant use and cognitive decline in community-dwelling elderly people - The Three-City Cohort
Isabelle Carrière, Joanna Norton, Amandine Farré, et al.
Pharmacoepidemiology and Drug Safety
|
February 26, 2009
Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study
Pernelle Noize, Fabienne Bazin, Carole Dufouil, et al.
Leukemia & Lymphoma
|
September 24, 2015
Patterns and effectiveness of bortezomib use according to age in the VESUVE cohort
Angela Grelaud, Annie Fourrier-Réglat, Olivier Fitoussi, et al.
Therapie
|
March 13, 2019
Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France
Anne Bénard-Laribière, Pernelle Noize, Pierre-Oliver Girodet, et al.
Journal of Geriatric Oncology
|
April 18, 2016
Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohort
Magali Rouyer, Annie Fourrier-Réglat, Denis Smith, et al.
British Journal of Clinical Pharmacology
|
July 14, 2020
Effectiveness of first-line cetuximab in wild-type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort
Magali Rouyer, Eric François, Antonio Sa Cunha, et al.
Targeted Oncology
|
August 24, 2015
Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort
Magali Rouyer, Denis Smith, Christophe Laurent, et al.
Clinical Colorectal Cancer
|
January 12, 2019
Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study
Amandine Gouverneur, Juliette Coutureau, Jérémy Jové, et al.
Leukemia & Lymphoma
|
July 2, 2013
Real-life patterns of use and effectiveness of bortezomib: the VESUVE cohort study
Annie Fourrier-Réglat, Pernelle Noize, Thierry Facon, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Targeted Oncology
|
December 6, 2013
Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohort
Annie Fourrier-Réglat, Denis Smith, Magali Rouyer, et al.
BMC Medicine
|
April 21, 2017
Antidepressant use and cognitive decline in community-dwelling elderly people - The Three-City Cohort
Isabelle Carrière, Joanna Norton, Amandine Farré, et al.
Pharmacoepidemiology and Drug Safety
|
February 26, 2009
Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study
Pernelle Noize, Fabienne Bazin, Carole Dufouil, et al.
Leukemia & Lymphoma
|
September 24, 2015
Patterns and effectiveness of bortezomib use according to age in the VESUVE cohort
Angela Grelaud, Annie Fourrier-Réglat, Olivier Fitoussi, et al.
Therapie
|
March 13, 2019
Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France
Anne Bénard-Laribière, Pernelle Noize, Pierre-Oliver Girodet, et al.
Journal of Geriatric Oncology
|
April 18, 2016
Effectiveness and safety of first-line bevacizumab plus FOLFIRI in elderly patients with metastatic colorectal cancer: Results of the ETNA observational cohort
Magali Rouyer, Annie Fourrier-Réglat, Denis Smith, et al.
British Journal of Clinical Pharmacology
|
July 14, 2020
Effectiveness of first-line cetuximab in wild-type RAS metastatic colorectal cancer according to tumour BRAF mutation status from the EREBUS cohort
Magali Rouyer, Eric François, Antonio Sa Cunha, et al.
Targeted Oncology
|
August 24, 2015
Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort
Magali Rouyer, Denis Smith, Christophe Laurent, et al.
Clinical Colorectal Cancer
|
January 12, 2019
Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study
Amandine Gouverneur, Juliette Coutureau, Jérémy Jové, et al.
Leukemia & Lymphoma
|
July 2, 2013
Real-life patterns of use and effectiveness of bortezomib: the VESUVE cohort study
Annie Fourrier-Réglat, Pernelle Noize, Thierry Facon, et al.
Page
of 6